Tampon use, environmental chemicals and oxidative stress in the BioCycle study by Singh, Jessica et al.
RESEARCH Open Access
Tampon use, environmental chemicals and
oxidative stress in the BioCycle study
Jessica Singh1, Sunni L. Mumford2, Anna Z. Pollack3, Enrique F. Schisterman2, Marc G. Weisskopf4,
Ana Navas-Acien1 and Marianthi-Anna Kioumourtzoglou1*
Abstract
Background: Tampons are used by up to 86% of US women and are a rarely considered potential source of pesticide
and metal exposure. Tampons may be of particular concern given the likely higher absorption that occurs in the
vagina. Our objective was to examine the potential associations between tampon use and metal concentrations, and
biomarkers of inflammation and oxidative stress among healthy women.
Methods: We used information from a prospective cohort of 259 regularly menstruating women, aged 18–44,
followed for two menstrual cycles. Tampon use was assessed using information provided in participant study diaries.
Metal concentrations were measured from a blood sample collected at enrollment. Oxidative stress and inflammation
biomarker concentrations were determined from blood samples collected at up to 8 clinic visits for each cycle. Linear
regression models were used to estimate associations of tampon use with metal exposure, and linear mixed models to
estimate associations of tampon use with inflammation and oxidative stress biomarkers at different times during the
menstrual cycle.
Results: We observed non-significantly higher mean levels of mercury for tampon users compared to non-tampon
users (exp(β) = 1.25, 95% CI = 0.93, 1.68). We found no evidence of an association between tampon use and
inflammation biomarkers. We observed consistently higher isoprostane levels, an oxidative stress biomarker, among
tampon users compared to non-tampon users (e.g. exp.(β) = 1.05, 95%CI = 0.96, 1.16, for the average isoprostane
during the menstruating week); however, these results were not statistically significant.
Conclusions: While our results are not statistically significant, we observed suggestive associations between tampon
use and elevated levels of mercury and oxidative stress biomarkers. Although our finding should be interpreted in light
of our limitations, they indicate that tampons may be a source of exposure to metals and chemicals that have been
largely ignored, and any related health effects are an important public health concern.
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Background
The vaginal route is a potentially important yet under-
studied route of chemical exposure. Feminine hygiene
products are personal care products used by many
women for menstruation and vaginal discharge. Tam-
pons, a commonly used feminine hygiene product, with
50–86% of women in the United States report using
them during menstruation, are inserted into the vagina
to absorb menstrual blood [1]. Notably, the vagina is an
effective delivery route of drugs to the systemic circula-
tion system [2], suggesting that it could also effectively
deliver other compounds, like toxic chemicals, to the
circulation. This is due to the abundance of arteries,
blood and lymphatic vessels in the walls of the vagina
mucosa, and the fact that absorption through this route
bypasses first-pass metabolism, by directly entering the
peripheral circulation [2]. For instance, vaginal adminis-
tration of estradiol results in significantly higher blood
serum levels compared to oral administration [3]. Fur-
thermore, vulvar and vaginal tissues are more hydrated
and permeable compared to the skin on the rest of the
body, which may make these more susceptible to
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chemical exposure [4, 5]. Moreover, in addition to sys-
temic exposure, vaginal exposure to chemicals and drugs
can also have local effects on vaginal and cervical tissue
[6]. Therefore, if tampons do contain harmful chemicals,
tampon use may [1] be a potentially important source of
these chemicals via the vaginal route given the rapid ab-
sorption that occurs in the vagina and the cumulative
exposure to tampons over a women’s reproductive life
and [2] may also affect the epithelial integrity of vaginal
and cervical cells, potentially increasing susceptibility to
sexually transmitted infections.
Tampons are a potential source of chemical exposure.
Most tampons are made of cotton or cotton blends, al-
though some tampons are made solely of rayon. Agricul-
tural soils contain both metals and pesticides, which
originate from the use of fertilizers, sewage sludge, irri-
gation water and fertilizers containing metals, and the
direct application of pesticides [7, 8]. The accumulation
of metals in soils of cotton fields is an emerging public
health concern because of rapid industrial development
and increasing reliance on agrochemicals [7]. Studies
have shown that cotton plants can bio-accumulate vari-
ous metals, including lead, copper, zinc, and cadmium in
different parts of the plant [9, 10]. The chlorine bleach-
ing process may contribute to dioxins and furans in tam-
pons and fragrance chemicals, such as phthalates, are
likely to be found in scented products [1, 11]. Identifying
specific chemicals is challenging due to the lack of label-
ing requirement for tampons.
Metals like cadmium, lead, and mercury are known
environmental toxicants [12], and are thus especially of
concern. Metals have oxidation-reduction properties that
have been associated with enhancing oxidative damage,
an important risk factor in the development of chronic
inflammatory disease [12, 13]. Cadmium exposure has
been linked to kidney and cardiovascular disease in
humans [12, 13]. Lead and mercury exposures have
been associated with negative impacts on the nervous
system and with cardiovascular disease [12, 14]. Pesti-
cides like organophosphates are also known to induce
oxidative stress, and are related to multiple adverse
health effects [15, 16].
Therefore, women who use tampons may be exposed
to metals and/or pesticides if the cotton was grown in
metal contaminated soils or if pesticides were applied to
the cotton used in the tampons. The bleaching process
can create dioxins to which women can then be exposed
[17], and fragrance chemical exposure is plausible
though understudied. If women are exposed to metals
and/or pesticides via this source then they may be vul-
nerable to multiple adverse health effects. However,
since studies thus far have only investigated oral, dermal
or inhalation exposures, it is unknown if vaginal expos-
ure will have comparable findings.
Tampons are, thus, a not yet assessed potential source
of exposure to various metals and pesticides, which
should be of concern because of the multiple health ef-
fects related to the exposure of these environmental che-
micals. To our knowledge, there are no peer-reviewed
studies assessing the relationship between tampon use
and metal or pesticide concentrations. For this study, we
used existing data from the BioCycle Study to assess
whether tampon use is related to increased metal con-
centrations in blood. As pesticides are not available in
BioCycle, this hypothesis could not be directly tested in
this study. However, we hypothesized that any potential
exposure to metals and pesticides through tampon use
can be related to increased inflammation and oxidative
stress. We thus assessed the association between tampon




The BioCycle Study is a prospective cohort study that
was designed to understand the relationship between re-
productive hormone levels and oxidative stress during
the menstrual cycle [18]. Between 2005 and 2007, 259
healthy, regularly menstruating women – who
self-reported menstrual cycle lengths between 21 and 35
days for the past 6 months – were enrolled from West-
ern New York for up to two menstrual cycles [18]. Ex-
clusion criteria included women who planned to or were
actively trying to conceive, a self-reported body mass
index (BMI) < 18 or > 35 kg/m2 at baseline, not between
the ages of 18 and 44 years, and histories of gynecologic
or other chronic diseases [18]. Of the 259 women, 9
were followed for one menstrual cycle, and 250 were
followed for two menstrual cycles [18]. Blood samples
were collected at clinic visits for each cycle correspond-
ing to specific phases of the menstrual cycle, including
menstruation, mid- and late follicular phase, luteinizing
hormone surge, estimated day of ovulation, and early-,
mid-, and late luteal phase. Fertility monitors (Clearblue
Easy Fertility Monitor; Inverness Medical, Waltham,
MA) and personal cycle length histories were used to
determine the timing of visits [19]. Further information
on study design can be found elsewhere [18].
Exposure assessment
At the time of enrollment, participants were asked to
complete a health questionnaire, which included ques-
tions related to their menstrual cycle. Participants were
asked to report the type of feminine hygiene product
they used while menstruating (sanitary napkins, tam-
pons, both, or other). Participants were also asked to
complete a daily diary during the study which asked
questions regarding their specific feminine hygiene
Singh et al. Environmental Health           (2019) 18:11 Page 2 of 9
product use if they reported any menstrual bleeding dur-
ing their participation in the study [20].
To assess tampon use, we considered any use during
the study period (any use versus none) using the infor-
mation provided in the diaries. We also calculated the




Cadmium, lead, and mercury were measured from a sin-
gle whole-blood sample that was collected at enrollment,
an average of 16 days before the first clinic visit, in ethyl-
enediaminetetraacetic acid (EDTA) purple-topped tubes,
which were prescreened for trace metals [21]. Blood cad-
mium, lead and mercury levels were determined by in-
ductively coupled plasma mass spectrometry at the
CDC’s Division of Laboratory Sciences, National Center
for Environmental Health [21]. Mercury levels represent
the total mercury concentration in blood from all forms
of mercury [21]. The limits of detection (LODs) for cad-
mium, lead and mercury were 0.20 μg/L (27% < LOD),
0.25 μg/dL (0% < LOD) and 0.33 μg/L (12% < LOD), re-
spectively. All machine-read values were included in
analyses, even those that were below the LOD.
Oxidative stress and inflammation biomarkers
Oxidative stress and inflammation biomarker concentra-
tions were determined from blood samples collected at
each of the 8 clinic visits for both cycles [22–25]. F2-8α
isoprostanes (isoprostane), thiobarbituric acid reactive
substances (TBARS), human serum paraoxonase 1 ary-
lesterase (PON1A), and human serum paraoxonase 1
paraoxonase (PON1P) are biomarkers of oxidative stress,
and C-reactive protein (CRP) is a biomarker of chronic
inflammation. Isoprostane and TBARS levels were mea-
sured in coagulated plasma collected in EDTA
purple-topped tubes, and PON1A, PON1P, and CRP
levels were measured in anticoagulated serum collected
in red-topped tubes. Isoprostane levels were determined
using a gas chromatography-mass spectrometry-based
method at the Molecular Epidemiology and Biomarker
Research Laboratory of the University of Minnesota
(Minneapolis, MN) [24]. TBARS levels were determined
using OxiTech reagent kits at the Oxidative Stress Re-
search Laboratory of the University at Buffalo [22, 24].
PON1A and PON1P levels were determined using the
Cobas Fara II chemistry analyzer [25]. CRP levels were
determined using IMMULITE 2000 High Sensitivity
CRP chemiluminescent immunoassay [23].
To assess the short and long-term effects of tampon
use on oxidative stress and inflammation, i.e. both dur-
ing and post-menstruation, five variables representing
different time periods in the women’s menstrual cycle
were created. Specifically, we assessed biomarker levels dur-
ing menses and the early-follicular phase visits separately,
menstruating week (by estimating the average of the men-
ses and early-follicular phase visits), the average biomarker
concentration during entire cycle, and, finally, the average
concentrations during the cycle post-menstruation (the
average of visits around expected ovulation and through
the luteal phase). For CRP, values larger than 10mg/L were
excluded from analysis, as those values are indicative of in-
fection [26].
Statistical analysis
Descriptive statistics were calculated for demographic
characteristics, metals, and oxidative stress and inflam-
mation biomarkers by tampon use during the study. We
calculated the geometric means and standard deviations
for the metals, oxidative stress and inflammation bio-
markers (using the cycle-wide averages) by tampon use.
Since these associations have never been investigated be-
fore, to identify potential confounders we conducted
univariate analyses to assess the relationship between
potential confounders and the dependent variables
(metals and biomarker concentrations), and the inde-
pendent variable (tampon use).
We employed linear regression models to estimate the
association between tampon use and metal exposure. Al-
though metals were measured at baseline, and thus be-
fore the reported tampon use, we assume that tampon
use patterns within woman are consistent over time and
reflective of past cycles as well. This is also evident in
our data, as the estimated intraclass correlation coeffi-
cient (ICC) for tampon use was 0.83. Because the metal
concentrations were highly skewed, these were natural
log-transformed to meet the assumption of normally dis-
tributed residuals of the linear regression. We used three
main modeling approaches, starting from a crude model
(no covariates other than tampon use included; Model
1), a basic model including age, BMI, smoking, educa-
tion, race, parity, and physical activity (Model 2), and an
extended model additionally adjusting for history of
birth control use and marital status (Model 3). Informa-
tion on all potential confounders was obtained from the
baseline questionnaires. Additionally, models for mer-
cury exposure were adjusted for fish consumption be-
cause exposure might reflect increased fish and seafood
consumption [27], and could be related to tampon use
through socioeconomic status (SES). For this analysis,
fish consumption was assessed as the sum (continuous)
of four variables from a food frequency questionnaire
(FFQ) administered at baseline: 1) fried fish and shellfish
and fish sandwich, 2) shellfish (not fried), 3) white fish
such as sole, halibut, snapper and cod, 4) and dark fish
such as salmon, mackerel and bluefish. For mercury, 5
participants were excluded from the models because
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they had mercury concentrations equal to 0 μg/L, and
thus the natural log was not defined. Of these, 1 partici-
pant did not have information about tampon use, 2 were
tampon users and 2 were non-tampon users. Therefore,
exclusion of these participants from analyses is likely not
informative and would not induce bias. As a sensitivity
analysis, and to include all participants, we also used the
following transformation for mercury: log(Hg) + 1 and
repeated our analysis.
We employed linear mixed regression models to esti-
mate the association between tampon use and inflamma-
tion and oxidative stress biomarker concentrations,
using random intercepts for each subject to account for
within subject clustering, in separate models for each
menstrual cycle time period. Because the biomarker con-
centrations were highly skewed, these were natural
log-transformed to meet the assumption of normally dis-
tributed residuals of the linear regression. The same
three levels for confounding adjustment described above
were used.
For both the metals and biomarkers we repeated ana-
lyses restricting to non-smokers. Finally, we also repeated
Model 2 for the biomarkers including the number of tam-
pons used per cycle (continuous) as the exposure of inter-
est to evaluate a potential dose-response relationship. We
first included the number of tampon used as a linear term
in the model. To assess the assumption of linearity, we re-
peated analyses using generalized additive mixed models
(GAMMs) and a penalized spline for the number of tam-
pons used. The number of degrees of freedom for the
spline was selected using the generalized cross-validation
criterion (GCV).
We present the results as the ratio of the expected
geometric mean for those who used tampons over those
who did not (exp(β)) and 95% confidence intervals (95%
CI). All statistical analyses were conducted using the R
Statistical Software, version 3.4.0 (Foundation for Statis-
tical Computing, Vienna, Austria).
Results
Metals and oxidative stress and inflammation biomarkers
in blood
A total of 158 (62%) BioCycle participants were tampon
users (Table 1). Among them, a median of 4 tampons were
used per cycle (IQR: 3–5). Tampon users were more likely to
be white (79.6%), have more than a high school education
(89.5%), be single (68.4%), non-smokers (94.7%), used birth
control in the past (62.0%), nulliparous (68.5%) and be highly
physical active (64.5%). For tampon users, the geometric
mean cadmium level was 0.26 μg/L, lead level was 0.85μg/L,
and mercury level was 1.08 μg/L. The geometric mean
PON1A level was 113.12 μmol/min/L, isoprostane level was
47.80 pg/mL, PON1P level was 179.35 μmol/min/L, and
CRP level was 1.32mg/L. TBARS blood levels were similar
for both tampon and non-tampon users.
Metals, oxidative stress and inflammation biomarkers by
tampon use
Results for models 1, 2, and 3 for blood metals levels were
overall similar (Table 2). After adjustment for age, ethni-
city, education, smoking status, BMI, parity, physical activ-
ity, and fish consumption (for mercury exposure), tampon
users had non-significantly higher geometric mean ratio
of blood mercury compared to non-users (exp(β) = 1.25,
95% CI = 0.93, 1.68) (Table 2, Model 2). When using the
log(Hg) + 1 transformation for mercury, the results were
similar and statistically significant (exp(β) = 1.16, 95% CI
= 1.02, 1.29).
Results for the biomarker models are presented in Table 3
and Figure 1. After adjustment, tampon users had higher
mean levels of blood isoprostane during menses and the
early-follicular phase, and menstruating week compared to
non-tampon users (Table 3, Model 2). For TBARS, tampon
users had non-significantly higher levels for the entire cycle,
and the cycle except the menstruation week. For PON1P,
tampon users had non-significantly lower levels for the cycle
and the cycle except the menstruation week. For CRP, the re-
sults were mixed with wide confidence intervals across the
different time periods in the women’s menstrual cycle.
When restricting analysis to non-smokers, the overall
results were similar to the results presented in Table 3.
For TBARS, tampon users had higher levels for the en-
tire cycle (Additional file 1: Table S1). Analysis of the
continuous variable (number of tampons used per cycle)
showed similar results to the binary tampon use analysis
(Additional file 1: Table S2), with no evidence for devia-
tions from linearity, as selected by GCV in GAMM
models (estimated df = 1).
Discussion
We observed increased, albeit not significantly so, levels
of blood mercury, and decreased levels of blood cad-
mium and lead for women who used tampons, although
this decrease was much weaker than the increase for
mercury. We also observed increased levels of oxidative
stress biomarkers during different times of the menstrual
cycle, with isoprostane having increased levels during
the menstruation week for women who used tampons.
Moreover, women who used tampons tended to have
higher TBARS and lower PON1P levels during the cycle
except from the menstruation week. However, our re-
sults were not statistically significant. Therefore, our
study provides some suggestive evidence that there may
be an association between tampon use and oxidative
stress, but more studies are warranted.
Metals have oxidation-reduction properties that have
been associated with enhancing oxidative damage, which
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is an important risk factor in the development of chronic
inflammatory disease [12, 13]. Metal exposure may de-
press the function of lipid-associated enzymes, which are
thought to protect against lipid peroxidation and may
have implications for cardiovascular disease risk with
aging and cumulative exposures [25]. Pesticides are also
known to induce oxidative stress and inflammation, and
are related to multiple adverse health effects [16, 28].
For example, exposure to organophosphates can induce
oxidative stress in humans, showing evidence of lipid per-
oxidation in human erythrocytes [15]. In our study, we
found isoprostane and TBARS, biomarkers of lipid peroxi-
dation, to be non-significantly higher in tampon users
than non-tampon users. Increased levels of these bio-
markers, thus, could indicate increased oxidative stress re-
lated with tampon use. In addition, we found lower levels
Table 1 Demographics and Metal and Biomarker concentrations by Tampon Use







< High school 10.53 17.20
> High school 89.47 82.80
Marital Status (%)





Birth Control Use (%)
Yes 62.00 40.86
No 38.00 59.14
Parous (%) 31.54 20.65





Age [years (mean (SD))] 27.87 (8.66) 27.16 (7.73)
BMI [(kg/m2 (mean (SD))] 23.91 (3.63) 24.43 (4.27)
Metal Concentrations
Cadmium [μg/L (GM (SD))]a 0.26 (1.90) 0.33 (1.90)
Lead [μg/dL (GM (SD))]a 0.85 (1.53) 1.01 (1.62)
Mercury [μg/L (GM (SD))]a 1.08 (2.75) 1.01 (2.47)
Biomarker Concentrations
TBARS [nmol/mL (GM (SD))]b 0.85 (1.27) 0.85 (1.25)
PON1A [μmol/min/L (GM (SD))]b 113.12 (1.24) 111.39 (1.22)
PON1P [μmol/min/L (GM (SD))]b 179.35 (1.84) 212.90 (1.83)
Isoprostane [pg/mL (GM (SD))]b 47.80 (1.37) 46.11 (1.45)
CRP [mg/L (GM (SD))]b 1.32 (6.48) 3.17 (13.60)
aGeometric mean (standard deviation) blood metal levels
bGeometric mean biomarker concentrations (standard deviation) measured from the created cycle variable
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of PON1P, an antioxidant enzyme known to hydrolyze ex-
ogenous organophosphate compounds [29–31], which
could indicate decreased ability to combat oxidative stress
among tampon users. These increases in oxidative stress
biomarkers and decrease in antioxidants may be due to
exposure to metals, pesticides or other chemicals present
in the tampons.
Tampons may be a source of exposure to chemicals
that have been related to oxidative stress and inflamma-
tion. DeVito and Schecter [17], for instance, assessed the
dioxin content in tampons, and found detectable con-
centrations of five dioxins in four different brands of
tampons with variability in exposure levels across the
different brands; however, daily dietary intake of dioxins
exceeded daily intake of dioxins from tampons. These
findings were consistent with those reported previously
[32] in that most of the dioxins found were below the
detection limit or estimated detection limits. Import-
antly, neither of these two studies assumed an absorbed
dose via the vaginal route, which may have resulted in
under-estimated dioxin exposure from tampons. Experi-
mental evidence confirmed the presence of dioxin in
cotton balls [33], with implications for tampons which
have yet to be explored. In NHANES 2001–2004,
women using tampons had a 6.1 and 4.1% increase in
urinary monoethyl phthalate and mono-n-butyl phthal-
ate, metabolites of diethyl phthalate and di-n-butyl
phthalate, compared to not using tampons, although the
differences were not statistically significant (n = 731)
[34]. Phthalates are expected to be an important group
of chemicals in fragranced tampons, although exposure
to tampon-related fragrance chemical in general has not
been studied. These studies suggest that tampons may
be a source of exposure to various chemicals that are re-
lated to oxidative stress and inflammation [35–38].
Our study is the first one, to our knowledge, to investi-
gate tampons as a potential source of exposure to metals
and other chemicals that may result in elevated inflam-
mation and oxidative stress. We were able to use data
from a well-characterized cohort with detailed informa-
tion on tampon use and oxidative stress and inflamma-
tion biomarkers measured at multiple points during the
menstrual cycle. Our findings, nevertheless, should be
interpreted in light of our limitations. First, and most
importantly, the BioCycle Study was not designed to
study tampon use and tampon-related chemical expo-
sures. While the BioCycle Study was designed to study
oxidative stress and inflammation, metal exposure was
not measured in the same way as the mechanistic bio-
markers. The metals were measured from a single
whole-blood sample collected approximately 16 days be-
fore the beginning of the first menstrual cycle during the
study and no additional collection was obtained before
Fig. 1 Ratio of the expected geometric mean for those who used tampons over those who did not (exp(β)) and 95% confidence intervals for
Blood Oxidative Stress and Inflammation Biomarkers for Model 2
Table 2 exp(β)a of Tampon Use and 95% Confidence Intervals
(95% CIs) for Blood Metals
Model 1b Model 2c Model 3d
exp(β) (95% CI) exp(β) (95% CI) exp(β) (95% CI)
Metals
Cadmium (μg/L) 0.81 (0.69, 0.96) 0.94 (0.78, 1.12) 0.94 (0.78, 1.14)
Lead (μg/dL) 0.85 (0.75, 0.95) 0.92 (0.80, 1.05) 0.91 (0.80, 1.05)
Mercury (μg/L)e 1.07 (0.83, 1.37) 1.25 (0.93, 1.68) 1.24 (0.92, 1.67)
aRatio of the expected geometric mean for those who used tampons over
those who did not
bCrude model (no covariates other than tampon use included)
cBasic model including age, BMI, smoking, education, race, parity, and
physical activity
dExtended model additionally adjusting for birth control use and marital status
eModels 2 and 3 for mercury additionally adjusted for fish consumption
Singh et al. Environmental Health           (2019) 18:11 Page 6 of 9
the second menstrual cycle. This may not have accur-
ately represented the levels of these metals when the
women were using tampons in cycles one and two.
However, we believe that tampon use patterns are con-
sistent across cycles, as also shown by the estimated
ICC. Given the potentially missed critical exposure win-
dow, the fact that other sources of exposure also exist,
and that – since the study was not designed for our hy-
pothesis – no other tampon-relevant chemicals were
measured (e.g. pesticides), we would expect exposure
measurement error to be an important source of bias in
our study. However, since there is no reason to believe
that any error is related to tampon use, any bias would
be towards the null, which may explain our null findings.
Tampon use was self-reported; therefore, exposure
measurement error is also likely. However, there is no
reason to believe that any misclassification in
self-reported tampon use is related to the dependent
variables included in our analyses, and, thus, any bias is
expected to be towards the null. Another limitation of
this study is that the sample size is small, limiting our
power to detect significant associations. Also, our results
may not be generalizable because most of the partici-
pants were highly educated. Finally, we cannot exclude
Table 3 exp(β)a of Tampon Use and 95% Confidence Intervals (95% CIs) for Blood Oxidative Stress and Inflammation Biomarkers
Model 1b Model 2c Model 3d
exp(β) (95% CI) exp(β) (95% CI) exp(β) (95% CI)
TBARS (nmol/mL)
Menses 0.98 (0.93, 1.03) 0.99 (0.93, 1.05) 0.99 (0.94, 1.05)
Early-follicular phase 0.99 (0.94, 1.04) 1.00 (0.95, 1.06) 1.01 (0.95, 1.06)
Menstruating Week 0.99 (0.94, 1.03) 0.99 (0.94, 1.05) 1.00 (0.95, 1.05)
Cycle 0.99 (0.94, 1.03) 1.02 (0.99, 1.07) 1.00 (0.95, 1.05)
Cycle except menstruating week 1.02 (0.98, 1.06) 1.03 (0.99, 1.08) 1.04 (0.99, 1.08)
PON1A (μmol/min/L)
Menses 1.03 (0.99, 1.07) 1.03 (0.99, 1.08) 1.03 (0.99, 1.08)
Early-follicular phase 1.00 (0.96, 1.04) 1.03 (0.99, 1.08) 1.00 (0.96, 1.04)
Menstruating Week 1.01 (0.98, 1.05) 1.02 (0.98, 1.05) 1.00 (0.96, 1.04)
Cycle 1.00 (0.97, 1.03) 1.00 (0.97, 1.03) 1.00 (0.97, 1.03)
Cycle except menstruating week 1.00 (0.97, 1.03) 1.00 (0.97, 1.03) 1.00 (0.97, 1.03)
PON1P (μmol/min/L)
Menses 0.87 (0.78, 0.98) 1.02 (0.91, 1.15) 1.02 (0.91, 1.15)
Early-follicular phase 0.90 (0.81, 1.00) 1.02 (0.91, 1.14) 1.02 (0.91, 1.14)
Menstruating Week 0.90 (0.82, 0.99) 1.01 (0.91, 1.11) 1.01 (0.91, 1.12)
Cycle 0.91 (0.86, 0.97) 0.95 (0.90, 1.02) 0.95 (0.89, 1.02)
Cycle except menstruating week 0.91 (0.86, 0.98) 0.96 (0.90, 1.03) 0.96 (0.90, 1.03)
Isoprostane (pg/mL)
Menses 1.09 (1.00, 1.19) 1.04 (0.95, 1.15) 1.04 (0.95, 1.14)
Early-follicular phase 1.09 (1.01, 1.19) 1.05 (0.96, 1.15) 1.05 (0.96, 1.15)
Menstruating Week 1.09 (1.01, 1.19) 1.05 (0.96, 1.15) 1.05 (0.96, 1.14)
Cycle 1.07 (1.00, 1.15) 1.03 (0.96, 1.11) 1.03 (0.96, 1.11)
Cycle except menstruating week 1.06 (0.99, 1.12) 1.02 (0.95, 1.09) 1.02 (0.95, 1.09)
CRP (mg/L)
Menses 1.13 (0.91, 1.41) 1.10 (0.88, 1.38) 1.06 (0.85, 1.32)
Early-follicular phase 0.93 (0.75, 1.15) 0.96 (0.78, 1.20) 0.93 (0.75, 1.16)
Menstruating Week 0.99 (0.81, 1.22) 1.01 (0.82, 1.25) 0.98 (0.80, 1.20)
Cycle 0.94 (0.77, 1.12) 0.95 (0.77, 1.16) 0.94 (0.76, 1.15)
Cycle except menstruating week 0.89 (0.73, 1.10) 0.90 (0.73, 1.11) 0.90 (0.73, 1.11)
aRatio of the expected geometric mean for those who used tampons over those who did not
bCrude model (no covariates other than tampon use included)
cBasic model including age, BMI, smoking, education, race, parity, and physical activity
dExtended model additionally adjusting for birth control use and marital status
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the possibility of residual confounding; although we
assessed multiple variables as potential confounders,
these associations have never before been examined, and
we were limited to assess confounding by variables for
which we had information. There are substantial fluctua-
tions in the levels of oxidative stress and inflammation
biomarkers during the menstrual cycle [39]. Although
we cannot exclude the possibility that a variable exists
that covaries with these fluctuations and tampon use, we
do not believe that this potential source of unmeasured
confounding is likely. Rather, the ability to capture these
fluctuations with the multiple measurements of these
biomarkers during the menstrual cycle is a strength of
our study.
Conclusion
In conclusion, we found suggestive evidence that women
who used tampons had increased levels of mercury, and
oxidative stress biomarkers during different times of the
menstrual cycle, but these increases were not statistically
significant. While our study lacked statistical power, ex-
posure to chemicals in tampons and their potential
health effects are important public health concerns. The
vaginal exposure route has been so far overlooked, al-
though it is an extremely important route because of the
rapid absorption that occurs in the vagina and the wide-
spread use of tampons. Indeed, many women could be
exposed to chemicals present in tampons as 50–86% of
women in the United States report using tampons [1].
Tampon use is a potentially important, yet understudied,
source of chemical exposure that could be associated
with adverse health. This potentially important public
health issue requires additional research efforts, includ-
ing the chemical assessment of tampons and the con-
duction of larger and sufficiently-powered biomarker
studies of tampon users to assess the importance of tam-
pon use as a chemical exposure pathway.
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